These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20516464)

  • 21. Concerns about consensus guidelines for QTc interval screening in methadone treatment.
    Byrne A
    Ann Intern Med; 2009 Aug; 151(3):216; author reply 218-9. PubMed ID: 19652191
    [No Abstract]   [Full Text] [Related]  

  • 22. Concerns about consensus guidelines for QTc interval screening in methadone treatment.
    Cohen SP; Mao J
    Ann Intern Med; 2009 Aug; 151(3):216-7; author reply 218-9. PubMed ID: 19652190
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic methadone therapy complicated by torsades de pointes: a case report.
    Pimentel L; Mayo D
    J Emerg Med; 2008 Apr; 34(3):287-90. PubMed ID: 18022786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.
    Gil M; Sala M; Anguera I; Chapinal O; Cervantes M; Guma JR; Segura F
    Am J Cardiol; 2003 Oct; 92(8):995-7. PubMed ID: 14556883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral erythromycin and the risk of sudden death.
    Harris JD; de Leon-Casasola OA
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669121
    [No Abstract]   [Full Text] [Related]  

  • 27. Methadone and QT prolongation in HIV-infected patients.
    Lucchini A; Barbaro G; Barbarini G
    Am J Cardiol; 2004 Jul; 94(1):147-8. PubMed ID: 15219532
    [No Abstract]   [Full Text] [Related]  

  • 28. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
    Pearson EC; Woosley RL
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone and torsade de pointes: case report and review of the literature.
    Iskandar SB; Abi-Saleh BS; Mechleb BK; Fahrig SA
    Tenn Med; 2007 Feb; 100(2):35-7, 42. PubMed ID: 17378505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone and torsade de pointes: how can we better understand the association?
    Hasnain M; Vieweg WV; Breden Crouse EL; Hancox JC
    Am J Med; 2013 Sep; 126(9):757-8. PubMed ID: 23968900
    [No Abstract]   [Full Text] [Related]  

  • 31. Methadone-induced Torsade de pointes tachycardias.
    Sticherling C; Schaer BA; Ammann P; Maeder M; Osswald S
    Swiss Med Wkly; 2005 May; 135(19-20):282-5. PubMed ID: 15986265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methadone and arrhythmia--final comment].
    Waal H; Krook AL; Hansteen V
    Tidsskr Nor Laegeforen; 2007 Mar; 127(7):913; author reply 913. PubMed ID: 17435820
    [No Abstract]   [Full Text] [Related]  

  • 33. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.
    Ehret GB; Desmeules JA; Broers B
    Expert Opin Drug Saf; 2007 May; 6(3):289-303. PubMed ID: 17480178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged QT interval and methadone: implications for palliative care.
    Wilcock A; Beattie JM
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):252-7. PubMed ID: 19797957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heart arrhythmia and sudden death during methadone therapy].
    Andersen HT; Ekgren JS
    Tidsskr Nor Laegeforen; 2007 Jan; 127(1):63. PubMed ID: 17205096
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular-associated disease in an addicted population: an observation study.
    Demarie D; Marletta G; Imazio M; Cappa C; Ferro S; Compostino R; De Vivo E; Trinchero R; Bignamini E
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):51-4. PubMed ID: 21135593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Cassin M; Meneguzzo N; Viel E; Lestuzzi C; Di Gennaro G; Nicolosi GL
    Ital Heart J Suppl; 2004 Sep; 5(9):735-40. PubMed ID: 15568612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
    J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Torsade de pointes: a severe and unknown adverse effect in a patient taking methadone].
    Vodoz JF; Jaquier F; Lamy O
    Praxis (Bern 1994); 2003 Oct; 92(41):1748-50. PubMed ID: 14587370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.